Abstract
The reaction of cis-[PtCl 2(Me 2SO) 2] with 1 equiv. of each of the amidoximes RC(NH 2)NOH in neutral media in MeOH results in the formation of complexes cis-[PtCl 2{RC(NH 2)NOH}(Me 2SO)] (5 examples; 83-98% isolated yields). In the presence of 2 equiv. of NaOH in MeOH solution, the reaction of cis-[PtCl 2(Me 2SO) 2] with 1 equiv. of each of the amidoximes RC(NH 2)NOH leads to [Pt{RC(NH)NO}(Me 2SO) 2] (7 examples; 74-95% isolated yields). All new complexes were characterized by C, H, and N elemental analyses, HRESI +-MS, IR, 1H, 13C{ 1H}, and CP-MAS TOSS 13C{ 1H} NMR spectroscopies, and additionally by single-crystal XRD (for seven species). The cytotoxic potency of six compounds was determined in the human cancer cell lines CH1/PA-1, A549, SK-BR-3, and SW480. Generally, the second class of complexes containing chelating amidoximato ligands shows much higher cytotoxicity than the non-chelate amidoxime analogs, despite the lack of easily exchangeable chlorido ligands. Especially, the complex [Pt(p-CF 3C 6H 4C(NH)NO)(Me 2SO) 2] displays a remarkable activity in the inherently cisplatin resistant SW480 cell line (0.51 μM vs. 3.3 μM).
Original language | English |
---|---|
Pages (from-to) | 6840-6848 |
Number of pages | 9 |
Journal | New Journal of Chemistry |
Volume | 41 |
Issue number | 14 |
DOIs | |
Publication status | Published - 21 Jul 2017 |
Austrian Fields of Science 2012
- 104003 Inorganic chemistry
- 301904 Cancer research
Keywords
- VITRO ANTICANCER ACTIVITY
- OXIME LIGANDS
- STRUCTURAL-CHARACTERIZATION
- NEXT-GENERATION
- DRUGS
- AGENTS
- DMSO
- 1,2,4-OXADIAZOLES
- PALLADIUM(II)
- CISPLATIN